184 related articles for article (PubMed ID: 34659551)
1. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma.
Zhang X; Guo Y; Li H; Han L
J Cancer; 2021; 12(22):6610-6619. PubMed ID: 34659551
[No Abstract] [Full Text] [Related]
2. Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma.
Qiu C; Zhang X; Huang B; Wang S; Zhou W; Li C; Li X; Wang J; Yang N
Onco Targets Ther; 2020; 13():10631-10640. PubMed ID: 33116640
[TBL] [Abstract][Full Text] [Related]
3. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.
Zhao LX; Gong ZQ; Zhang Q; He DL; Ge RL; Meng J; Ren H; Fan YG; Wang ZY
J Control Release; 2023 Jul; 359():12-25. PubMed ID: 37244298
[TBL] [Abstract][Full Text] [Related]
4. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.
Sun Y; Berleth N; Wu W; Schlütermann D; Deitersen J; Stuhldreier F; Berning L; Friedrich A; Akgün S; Mendiburo MJ; Wesselborg S; Conrad M; Berndt C; Stork B
Cell Death Dis; 2021 Oct; 12(11):1028. PubMed ID: 34716292
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV ameliorates spinal cord injury through controlling ferroptosis in H
Zhou Y; Li L; Mao C; Zhou D
Ann Transl Med; 2022 Nov; 10(21):1176. PubMed ID: 36467371
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV Inhibits Bleomycin-Induced Ferroptosis in Human Umbilical Vein Endothelial Cells by Mediating LPC.
Sheng S; Xu J; Liang Q; Hong L; Zhang L
Oxid Med Cell Longev; 2021; 2021():6241242. PubMed ID: 34760046
[TBL] [Abstract][Full Text] [Related]
7. Iron-Based Nanovehicle Delivering Fin56 for Hyperthermia-Boosted Ferroptosis Therapy Against Osteosarcoma.
Zhang Y; Song Q; Zhang Y; Xiao J; Deng X; Xing X; Hu H; Zhang Y
Int J Nanomedicine; 2024; 19():91-107. PubMed ID: 38192634
[TBL] [Abstract][Full Text] [Related]
8. Lys05 induces lysosomal membrane permeabilization and increases radiosensitivity in glioblastoma.
Zhou W; Guo Y; Zhang X; Jiang Z
J Cell Biochem; 2020 Feb; 121(2):2027-2037. PubMed ID: 31642111
[TBL] [Abstract][Full Text] [Related]
9. Quercetin Promotes TFEB Nuclear Translocation and Activates Lysosomal Degradation of Ferritin to Induce Ferroptosis in Breast Cancer Cells.
An S; Hu M
Comput Intell Neurosci; 2022; 2022():5299218. PubMed ID: 35898781
[No Abstract] [Full Text] [Related]
10. Radiotherapy-activated NBTXR3 nanoparticles promote ferroptosis through induction of lysosomal membrane permeabilization.
Da Silva J; Bienassis C; Schmitt P; Berjaud C; Guedj M; Paris S
J Exp Clin Cancer Res; 2024 Jan; 43(1):11. PubMed ID: 38173001
[TBL] [Abstract][Full Text] [Related]
11. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
12. GDC-0941 enhances the lysosomal compartment via TFEB and primes glioblastoma cells to lysosomal membrane permeabilization and cell death.
Enzenmüller S; Gonzalez P; Karpel-Massler G; Debatin KM; Fulda S
Cancer Lett; 2013 Feb; 329(1):27-36. PubMed ID: 23000516
[TBL] [Abstract][Full Text] [Related]
13. Sodium Sulfite-Triggered Hepatocyte Ferroptosis
Liu M; Lu J; Chen Y; Zhang S; Guo J; Guan S
J Agric Food Chem; 2023 Nov; 71(43):16310-16322. PubMed ID: 37871339
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine Mitigates Ferroptosis and Inflammation in Hippocampal Neurons After Subarachnoid Hemorrhage by Activating the Nrf2/TXNRD1 Axis.
Hu J; Cheng M; Jiang C; Liu L; He Z; Liu L; Yao Y; Li Z; Wang Q
Mol Neurobiol; 2024 Feb; 61(2):1044-1060. PubMed ID: 37676391
[TBL] [Abstract][Full Text] [Related]
15. SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
Liu Y; Xiong R; Xiao T; Xiong L; Wu J; Li J; Feng G; Song G; Liu K
BMC Cancer; 2022 Dec; 22(1):1304. PubMed ID: 36513999
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain.
Yang FC; Wang C; Zhu J; Gai QJ; Mao M; He J; Qin Y; Yao XX; Wang YX; Lu HM; Cao MF; He MM; Wen XM; Leng P; Cai XW; Yao XH; Bian XW; Wang Y
Lab Invest; 2022 Jul; 102(7):741-752. PubMed ID: 35351965
[TBL] [Abstract][Full Text] [Related]
17. Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells.
Erdem İS
Anticancer Agents Med Chem; 2023; 23(19):2154-2160. PubMed ID: 37622695
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
19. Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy.
Fu W; Xu L; Chen Y; Zhang Z; Chen S; Li Q; You X
Prostate; 2024 Feb; 84(3):223-236. PubMed ID: 37904332
[TBL] [Abstract][Full Text] [Related]
20. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
